SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

EQT Corp. is a natural gas production company, which engages in the provision of supply, transmission, and distribution of natural gas. The company was founded in 1888 and is headquartered in Pittsburgh, PA.

EQT Corp

EQT is trending as the community discusses a recent insider sale by the Chief Legal Officer, raising concerns about the company's prospects despite a bullish natural gas outlook tied to AI data center demand. Technical analysis suggests the stock is currently overbought, prompting discussions around potential pullbacks and entry points. Trading strategies involving options and specific price targets are also circulating among investors.

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.

Cytek BioSciences Inc

Recent analyst ratings adjustments from Piper Sandler and Goldman Sachs, along with community discussion around undervaluation, are contributing to $CTKB's increased visibility. Community members are also highlighting the company's technology and potential within the life science tools sector, viewing it as a hidden gem. Expanded risk factors and insider selling may also be influencing investor sentiment.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid community discussion around the release of Epstein files and Trump's alleged connections. Reactions are mixed, with some users defending Trump and others questioning his motives for potentially blocking the release. Broader discussions involve political divides and the stock's valuation relative to its fundamentals.

Cantor Equity Partners, Inc. is a blank check company, which engages in the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Cantor Equity Partners Inc. - Ordinary Shares - Class A

Cantor Equity Partners Inc

Cantor Equity Partners ($CEP) is trending due to community excitement surrounding its impending merger with Twenty One Capital ($XXI), a Bitcoin treasury company, and the potential ticker change. Discussions revolve around the merger's timeline, the value of CEP post-merger, and the influence of key figures like Jack Mallers and Tether. Some traders express skepticism while others anticipate a significant price surge upon completion of the merger.

BlockDAG

BlockDAG ($BDAG) is trending amid discussions about its ongoing presale and future potential, with the planned mainnet launch in Q1 2026. The community is focused on the length of the presale, recent team-ups (such as the Alpine F1 team partnership) and the availability and functionality of BlockDAG miners. Some users express skepticism, citing concerns about the project's legitimacy, while others remain optimistic about BlockDAG's potential returns.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

Mimedx Group is trending due to discussions around the potential impact of new CMS reimbursement rules for skin substitute products and a possible shift in market dynamics. The community is weighing the company's competitive advantages against concerns about future revenue and earnings, especially in light of analyst reports and guidance. Some investors express frustration with the company's leadership and advocate for a potential sale.

What is the project about?   Horizen is a modular privacy-first platform designed to make privacy technology, such as zero-knowledge proofs and TEEs accessible and usable across the web. Originally launched in 2017 as a fair launch, non-ICO project, Horizen is now undergoing a major evolution with the launch of Horizen 2.0, a next-generation Layer 3 (L3) appchain deployed on Base, the Ethereum Layer 2 developed by Coinbase.  Horizen 2.0 is built as an Ethereum-aligned Layer 3 appchain on Base, inheriting Ethereum's security while implementing its own application-level integrity guarantees.    Key components of Horizen’s security model include:  Ethereum-Aligned Security: As an appchain deployed on Base, Horizen 2.0 benefits from Base’s rollup security and settlement on Ethereum, ensuring robust finality and composability with other L2 and L3 applications.  Simplified and Secure Architecture: Unlike Horizen’s previous iterations (which used a hybrid PoW/PoS model), Horizen 2.0 focuses on application-level security, decentralization of its privacy layers, and composability with existing infrastructure — reducing complexity and increasing user safety.  Decentralized Privacy Stack: Horizen’s focus on decentralizing privacy infrastructure (e.g., decentralized proof generation) allows for modular, secure applications that uphold data confidentiality without compromising performance.    What makes your project unique?  Privacy-first Approach: Horizen integrates a diverse stack of privacy-enhancing technologies (PETs) — including zero-knowledge proofs (ZKPs), trusted execution environments (TEEs), attribute-based encryption (ABE), multi-party computation (MPC), and fully homomorphic encryption (FHE) — to deliver scalable, flexible, and future-ready privacy solutions across its platform.  First Privacy Appchain on Base: As an L3 on Base, Horizen benefits from Ethereum’s security and Base’s scalability, while enabling a privacy layer for any app on the network. This unlocks new possibilities for private identity, DeFi, onchain gaming, and compliant confidential transactions.  Zero-Knowledge, Without the Trade-Offs: Horizen 2.0 scales ZK privacy and verification by integrating with leading zk infrastructure providers such as Fermah, zkVerify, and Singularity, optimizing proof generation for performance, cost-efficiency, and developer usability.  Token Utility Expansion: ZEN’s updated tokenomics allocates 5 million unminted tokens toward strategic ecosystem growth. ZEN powers DAO governance, serves as a payment token in privacy apps, and supports a sustainability fund to accelerate privacy innovation.  Developer-Centric Design: With EVM compatibility, privacy-friendly tooling, and the ability to embed privacy directly into smart contracts, Horizen allows developers to build privacy-first apps without requiring deep cryptographic expertise.  DAO-Led Governance: Governed by the Horizen DAO and shaped through community proposals (ZENIPs), Horizen is evolving as a fully decentralized protocol with transparent development and decision-making.    What can your coin/token be used for?  Horizen 2.0 delivers performance, privacy, and scalability for developers building privacy-enabled and compliance-friendly applications, with significantly reduced cost and latency.  At the core of the ecosystem is ZEN, the native utility token used for governance, accessing privacy services, and fueling zkApp interactions. With its migration to Base, ZEN becomes an ERC-20 token, improving liquidity, interoperability, and composability across the broader Ethereum ecosystem.

ZenCash

ZenCash is trending as traders discuss its potential to follow the price action of ZCash, with some highlighting its listing on a new platform as a possible catalyst. Community members are actively watching key price levels and noting increased volatility across the market, while also pointing to the upcoming halving event. Some believe ZEN's privacy focus and limited supply could contribute to significant upward movement.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending amid discussion of its privacy features and a recent investment by Cypherpunk Technologies, backed by the Winklevoss twins, to accumulate ZEC. Community members are weighing in on the potential for ZEC to outperform Bitcoin, with some drawing comparisons to Litecoin's past performance and touting ZEC as a hedge against broader market downturns.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is trending as conversations highlight its strong community, even during market dips, with the community referring to itself as the "$DOG Army." There is growing excitement around the potential integration with Zap, and how it could affect exposure. Discussion also centers around $DOG's relationship with Bitcoin and the Rune revolution.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet's STRK is gaining attention as discussions revolve around its potential role in scaling Bitcoin and Ethereum through ZK-STARK technology. The community is actively discussing recent developments like the launch of BTCFi Season with significant STRK incentives and the integration of BTC bridges, aiming to unify Bitcoin and Ethereum layers. Additionally, the coin is being discussed in the context of its potential for staking and quantum-resistant security.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

M&G PLC Takes Position in Amicus Therapeutics, Inc. $FOLD

M&G PLC bought a new stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

GILD's Investigational Regimen for HIV Treatment Meets Primary Goal

Gilead's ARTISTRY-1 success boosts shares as its once-daily bictegravir/lenacapavir combo proves non-inferior to complex regimens.

Profund Advisors LLC Boosts Stock Holdings in Amicus Therapeutics, Inc. $FOLD

Profund Advisors LLC grew its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 57.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth?

Cytokinetics' shares surge to a 52-week high as investor optimism grows over FDA approval prospects for aficamten.

Connor Clark & Lunn Investment Management Ltd. Grows Stake in Amicus Therapeutics, Inc. $FOLD

Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 133.9% in the second quarter, according to the company in its...

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus

Immunovant posts a wider Q2 loss as R&D spending rises, but progress on IMVT-1402 and batoclimab fuels its pipeline momentum.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) have earned an average rating of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat.com reports...

Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to Trade

The consensus price target hints at a 76.3% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks.com featured highlights include EverQuote, Amicus, Lam Research and Cboe Global Markets EverQuote, Amicus, Lam Research and Cboe Global Markets

EverQuote, Amicus, Lam Research and Cboe Global Markets EverQuote, Amicus, Lam Research and Cboe Global Markets been highlighted in this Screen of The Week article.


Amicus Therapeutics (NASDAQ:FOLD) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Amicus Therapeutics (NASDAQ:FOLD - Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.12...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$9.48
Prev Close	$9.38
Open	$9.25
Dividend Yield	0.00%
50-Day Moving Average	$8.45
Beta	0.84
Avg. Volume	5.13M
PE Ratio	-212.08

52-Week High	$10.36
52-Week Low	$5.51
Market Capitalization	$2.92B
EPS (Annual)	-$0.1843
Price to Book	12.69
Revenue Per Employee	$1.06M
Enterprise Value/EBITDA	N/A

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc